Aromatasehemmer in der Therapie der Endometriose

In: Gynäkologische Endokrinologie · 2006 · vol. 4(3) , pp. 174–180 · doi:10.1007/s10304-006-0156-7 · W19754226
article OA: closed CC0
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex
AI-generated summary by claude@2026-06+body, 2026-06-07

This review elucidates the role of aromatase in endometriosis pathogenesis and evaluates aromatase inhibitors as a potential treatment option.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-07

This review examines the role of aromatase in the pathogenesis of endometriosis and summarizes existing clinical experience with aromatase inhibitors as potential therapies. It discusses that standard endometriosis treatment aims for a hypoestrogenic state using agents such as progestins, gestagen-focused contraceptives, GnRH analogues, and danazol, and notes limitations including insufficient symptom relief, recurrence, and side effects in some patients. The paper’s key conclusion is that aromatase inhibitors may represent an alternative therapeutic option based on new research linking aromatase to endometriosis biology, while the overall caveat is that the evidence is framed as “current insights” and “clinical experience,” without providing a single definitive trial result within the review text. This paper is centrally about endometriosis — it focuses on aromatase biology and aromatase inhibitors as a treatment option for endometriosis.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (51)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK